Cargando…
Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma
Fifteen patients with relapsed osteosarcoma were treated with an intensive combination chemotherapy schedule. Ifosfamide 2.5 g m(−2) daily and etoposide 150 mg m(−2) daily coincidentally for 3 days and high-dose methotrexate 8 g m(−2) (with folinic acid rescue) on days 10–14 in a planned 21-day cycl...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1999
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362262/ https://www.ncbi.nlm.nih.gov/pubmed/10098754 http://dx.doi.org/10.1038/sj.bjc.6690187 |